Gene · 3131
Papers1,870
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,870
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway. | Cancer Lett | 2023 | 36958694 | PubTator, text mining | PubMed |
| Prognostic value of cross-lineage expression of the myeloid-associated antigens CD13 and CD33 in adult B-lymphoblastic leukemia: A large real-world study of 1005 patients. | Cancer Med | 2023 | 36951610 | PubTator, text mining | PubMed |
| Identification and characterization of noncoding RNAs-associated competing endogenous RNA networks in major depressive disorder. | World J Psychiatry | 2023 | 36925948 | PubTator, text mining | PubMed |
| Daucosterol combined with umbilical cord mesenchymal stem cell-derived exosomes can alleviate liver damage in liver failure mice by regulating the IL-6/STAT3 signaling pathway. | Cancer Biol Ther | 2023 | 36919480 | PubTator, text mining | PubMed |
| Recent advances in the functional explorations of nuclear microRNAs. | Front Immunol | 2023 | 36911728 | PubTator, text mining | PubMed |
| The mast cell exosome-fibroblast connection: A novel pro-fibrotic pathway. | Front Med (Lausanne) | 2023 | 36910476 | PubTator, text mining | PubMed |
| Pediatric Acute Lymphoblastic Leukemia Emerging Therapies-From Pathway to Target. | Int J Mol Sci | 2023 | 36902091 | PubTator, text mining | PubMed |
| Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. | Cells | 2023 | 36899879 | PubTator, text mining | PubMed |
| CRS: a circadian rhythm score model for predicting prognosis and treatment response in cancer patients. | J Transl Med | 2023 | 36895015 | PubTator, text mining | PubMed |
| Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization. | Nat Commun | 2023 | 36894533 | PubTator, text mining | PubMed |
| Unique microRNA expression profiles in plasmic exosomes from intrahepatic cholestasis of pregnancy. | BMC Pregnancy Childbirth | 2023 | 36882772 | PubTator, text mining | PubMed |
| Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 36881404 | PubTator, text mining | PubMed |
| Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing. | Blood Adv | 2023 | 36848637 | PubTator, text mining | PubMed |
| Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors. | Front Oncol | 2023 | 36845720 | PubTator, text mining | PubMed |
| Innovation in the Development of Synthetic and Natural Ocular Drug Delivery Systems for Eye Diseases Treatment: Focusing on Drug-Loaded Ocular Inserts, Contacts, and Intraocular Lenses. | Pharmaceutics | 2023 | 36839947 | PubTator, text mining | PubMed |
| Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures. | Int J Mol Sci | 2023 | 36835631 | PubTator, text mining | PubMed |
| The Role of CREBBP/EP300 and Its Therapeutic Implications in Hematological Malignancies. | Cancers (Basel) | 2023 | 36831561 | PubTator, text mining | PubMed |
| NPM 1 Mutations in AML-The Landscape in 2023. | Cancers (Basel) | 2023 | 36831522 | PubTator, text mining | PubMed |
| Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models. | Biomedicines | 2023 | 36830879 | PubTator, text mining | PubMed |
| Genomic regulatory sequences in the pathogenesis of bipolar disorder. | Front Psychiatry | 2023 | 36824672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3131/papers?page=12